Key facts
- · Type: New offering first sale 2026-04-07 · Amount sold: $50M · Total offering: $50M · SEC filing
- · Type: New offering first sale 2025-03-17 · Amount sold: $48.58M · Total offering: $48.58M · SEC filing
- · Type: New offering first sale 2024-05-20 · Amount sold: $3M · Total offering: $3M · SEC filing
- · Type: New offering first sale 2024-08-30 · Amount sold: $8.27M · Total offering: $8.27M · SEC filing
NEW YORK, NEW YORK
Other Health Care
4
$109.85M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-10-01 | New offering first sale 2026-04-07 | $50M | $50M | details · SEC filing |
| 2025-04-01 | New offering first sale 2025-03-17 | $48.58M | $48.58M | SEC filing |
| 2024-11-21 | New offering first sale 2024-05-20 | $3M | $3M | SEC filing |
| 2024-11-21 | New offering first sale 2024-08-30 | $8.27M | $8.27M | SEC filing |
What do you want to do with Click Therapeutics, Inc.?
Who to contact
- David Klein — Executive Officer, Director
- Randall Stanicky — Executive Officer
- Cris De Luca — Director
- Jeffrey Berkowitz — Director
- Alex Zisson — Director
- Maria Forero — Director
- Muzammil Mansuri — Director
- Lezrene Cunningham — Ms. Cunningham served as a Director on the date that the board approved the Offering and on the Date of First Sale. She resigned prior to the date hereof.
- David Friedman — Director
- Anthony Costello — Director
- Bruce Robertson — Mr. Robertson was elected a Director after the Date of First Sale and resigned prior to the date hereof.
- Douglas Langa — Mr. Langa was elected a Director after the Date of First Sale.
- Round: Form D filed 2026-10-01
- Amount sold: $50M
- Industry: Other Health Care
- Based: NEW YORK, NEW YORK
People listed
- David Klein — Executive Officer, Director
- Randall Stanicky — Executive Officer
- Cris De Luca — Director
- Jeffrey Berkowitz — Director
- Alex Zisson — Director
- Maria Forero — Director
- Muzammil Mansuri — Director
- Lezrene Cunningham — Ms. Cunningham served as a Director on the date that the board approved the Offering and on the Date of First Sale. She resigned prior to the date hereof.
- David Friedman — Director
- Anthony Costello — Director
- Bruce Robertson — Mr. Robertson was elected a Director after the Date of First Sale and resigned prior to the date hereof.
- Douglas Langa — Mr. Langa was elected a Director after the Date of First Sale.
- Filing: Form D filed 2026-10-01
- Amount sold: $50M
- Industry group: Other Health Care
- Based: NEW YORK, NEW YORK
- Entity type: Corporation
We'll show it in your MentionFox inbox when Click Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Click Therapeutics, Inc. →Want the whole picture on Click Therapeutics, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Click Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Click Therapeutics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Click Therapeutics, Inc.'s own filings with the SEC. The people those filings name are on the team page.